API's
Active Pharmaceutical Ingredients
Active Pharmaceutical Ingredients
Ambroxol HCl SR Coated Pellets are a pharmaceutical formulation of the active ingredient Ambroxol Hydrochloride, designed for sustained release (SR). This means the drug is released over an extended period, which allows for less frequent dosing.
| Component | Function |
|---|---|
| Ambroxol Hydrochloride | Active Pharmaceutical Ingredient (API) |
| Sugar Spheres / MCC Spheres | Inert core or starter pellets |
| Hydroxypropyl Methylcellulose (HPMC) / Povidone (PVP) | Binder / Sub-coating polymer / Film former during layering (for drug and sub-coating layers) |
| Talc / Colloidal Silicon Dioxide | Anti-adherent / Glidant |
| Ethylcellulose (EC) / Hypromellose (HPMC) | Sustained-release coating polymer (provides controlled release of the API) |
| Dibutyl Phthalate (DBP) / Triethyl Citrate (TEC) / Polyethylene Glycol (PEG) | Plasticizer (for sustained-release coating) |
| Talc / Magnesium Stearate | Anti-sticking agent in coating / Glidant |
| Purified Water / Isopropyl Alcohol / Ethanol | Solvent (removed after processing) |
Outsourcing pellets through a trusted partner like Salius Pharma can be a strategic decision to save both time and resources, without compromising on quality or compliance.
Instead, partnering with Salius Pharma—a leading distributor aligned with USFDA-approved and WHO-GMP-certified manufacturers in India—allows you to leverage high-quality products, seamless logistics, and professional support under one roof.
We ensure prompt and reliable shipping worldwide. Delivery times may vary depending on destination, order volume, and regulatory requirements.
Looking to source Ambroxol HCl SR Coated or other high-quality pharmaceutical pellet formulations?
Whether you need Active Pharmaceutical Ingredients (APIs), excipients, or regulatory support, our team is ready to provide reliable, compliant, and cost-effective solutions tailored to your market needs.
The contents of this page and any attachments are intended solely for the designated recipient(s) and may contain confidential and/or privileged information protected by law.
Any patented products are excluded from our offerings in regions where such patents are currently in force.
They are used to treat respiratory conditions where thick or excessive mucus is a problem, such as acute and chronic bronchitis, bronchial asthma, and pneumonia. The medication helps to thin the mucous, making it easier to clear from the airways.
Their focus on providing compliant regulatory dossiers suggests a strong commitment to respecting intellectual property and adhering to local market regulations.
Common side effects are generally mild and may include nausea, vomiting, stomach upset, diarrhea, and a change in taste. If these or any other side effects persist or worsen, you should consult a doctor.
They provide key regulatory files like DMFs, CoPPs, and dossiers in CTD format to help partners register products in their home countries.